Nasally administered Lactobacillus rhamnosus strains differentially modulate respiratory antiviral immune responses and induce protection against respiratory syncytial virus infection

BMC Immunology

Volumn 14, Issue 1, 2013, Pages

  Tomosada, Yohsuke ^a   Chiba, Eriko ^a   Zelaya, Hortensia ^b,c   Takahashi, Takuya ^a   Tsukida, Kohichiro ^a   Kitazawa, Haruki ^a   Alvarez, Susana ^b,c   Villena, Julio ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^c UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Lactobacillus rhamnosus; Nasal treatment; Poly(I:C); Respiratory syncytial virus; Respiratory tract; Sntiviral immunity

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; POLYINOSINIC POLYCYTIDYLIC ACID; PROBIOTIC AGENT; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL RESISTANCE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; IMMUNOMODULATION; LACTOBACILLUS RHAMNOSUS; MOUSE; NONHUMAN; RECEPTOR UPREGULATION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY SYSTEM; STRAIN DIFFERENCE; VIRUS IMMUNITY;

ADMINISTRATION, INTRANASAL; ANIMALS; CYTOKINES; DISEASE RESISTANCE; FEMALE; HUMANS; IMMUNITY; LACTOBACILLUS RHAMNOSUS; LUNG INJURY; MICE; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; POLY I-C; RECEPTORS, PATTERN RECOGNITION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY SYSTEM;

EID: 84881420275     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-14-40     Document Type: Article

References (33)

1. Mizgerd JP. Acute lower respiratory tract infection. N Engl J Med 2008, 358:716-727. 10.1056/NEJMra074111, 2711392, 18272895.
2. Falade AG, Ayede AI. Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries-a review. Afr J Med Med Sci 2011, 40:293-308.
3. Simoes EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010, 126:256-262. 10.1016/j.jaci.2010.05.026, 20624638.
4. Weiss KA, Christiaansen AF, Fulton RB, Meyerholz DK, Varga SM. Multiple CD4+ T cell subsets produce immunomodulatory IL-10 during respiratory syncytial virus infection. J Immunol 2011, 187:3145-3154. 10.4049/jimmunol.1100764, 3304096, 21844390.
5. Villena J, Oliveira ML, Ferreira PC, Salva S, Alvarez S. Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. Int Immunopharmacol 2011, 11:1633-1645. 10.1016/j.intimp.2011.06.004, 21708293.
6. Salva S, Villena J, Alvarez S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections. International Journal of Food Microbiology 2010, 141:82-89. 10.1016/j.ijfoodmicro.2010.03.013, 20395002.
7. Salva S, Nunez M, Villena J, Ramon A, Font G, Alvarez S. Development of a fermented goats' milk containing Lactobacillus rhamnosus: in vivo study of health benefits. J Sci Food Agric 2011, 91:2355-2362. 10.1002/jsfa.4467, 21604277.
8. Villena J, Racedo S, Aguero G, Bru E, Medina M, Alvarez S. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J Nutr 2005, 135:1462-1469.
9. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004, 4:699-710. 10.1038/nri1439, 15343369.
10. Medina M, Villena J, Salva S, Vintini E, Langella P, Alvarez S. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae. Microbiol Immunol 2008, 52:399-409. 10.1111/j.1348-0421.2008.00050.x, 18667039.
11. Villena J, Barbieri N, Salva S, Herrera M, Alvarez S. Enhanced immune response to pneumococcal infection in malnourished mice nasally treated with heat-killed Lactobacillus casei. Microbiol Immunol 2009, 53:636-646. 10.1111/j.1348-0421.2009.00171.x, 19903264.
12. Villena J, Chiba E, Tomosada Y, Salva S, Marranzino G, Kitazawa H, Alvarez S. Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C). BMC Immunol 2012, 13:53. 10.1186/1471-2172-13-53, 3460727, 22989047.
13. Londhe VA, Belperio JA, Keane MP, Burdick MD, Xue YY, Strieter RM. CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection. J Inflamm (Lond) 2005, 2:4.
14. Stowell NC, Seideman J, Raymond HA, Smalley KA, Lamb RJ, Egenolf DD, Bugelski PJ, Murray LA, Marsters PA, Bunting RA, et al. Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir Res 2009, 10:43. 10.1186/1465-9921-10-43, 2694181, 19486528.
15. Hori T, Kiyoshima J, Shida K, Yasui H. Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice. Clin Diagn Lab Immunol 2001, 8:593-597. 96107, 11329464.
16. Gabryszewski SJ, Bachar O, Dyer KD, Percopo CM, Killoran KE, Domachowske JB, Rosenberg HF. Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol 2011, 186:1151-1161. 10.4049/jimmunol.1001751, 3404433, 21169550.
17. Barbieri N, Villena J, Herrera M, Salva S, Alvarez S. Nasally administered Lactobacillus rhamnosus accelerate the recovery of humoral immunity in B lymphocyte-deficient malnourished mice. J Nutr 2013, 143:227-235. 10.3945/jn.112.165811, 23269656.
18. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM, Tripp RA, Kurt-Jones EA, Finberg RW. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol 2009, 83:1492-1500. 10.1128/JVI.00671-08, 2620898, 19019963.
19. Hori T, Kiyoshima J, Shida K, Yasui H. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin Diagn Lab Immunol 2002, 9:105-108. 119906, 11777838.
20. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 2004, 31:358-364. 10.1165/rcmb.2003-0388OC, 15191912.
21. Furuhashi K, Suda T, Hasegawa H, Suzuki Y, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shibata K, et al. Mouse lung CD103+ and CD11bhigh dendritic cells preferentially induce distinct CD4+ T-cell responses. Am J Respir Cell Mol Biol 2012, 46:165-172. 10.1165/rcmb.2011-0070OC, 21908266.
22. Yoda K, Miyazawa K, Harata G, He F. Immunobiotics and antiviral immunity. Immunobiotics and Immunogenics 2013, Enfield, New Hampshire, USA: Science Publishers CRC Press Taylor & Francis Group, Kitazawa H, Villena J, Alvarez S.
23. Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, Yausi H. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol 2010, 50:597-602. 10.1111/j.1472-765X.2010.02844.x, 20438620.
24. Li F, Zhu H, Sun R, Wei H, Tian Z. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol 2012, 86:2251-2258. 10.1128/JVI.06209-11, 3302418, 22171263.
25. Bem RA, Domachowske JB, Rosenberg HF. Animal models of human respiratory syncytial virus disease. Am J Physiol Lung Cell Mol Physiol 2011, 301:L148-L156. 10.1152/ajplung.00065.2011, 3154630, 21571908.
26. Rutigliano JA, Graham BS. Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection. J Immunol 2004, 173:3408-3417.
27. Loebbermann J, Schnoeller C, Thornton H, Durant L, Sweeney NP, Schuijs M, O'Garra A, Johansson C, Openshaw PJ. IL-10 regulates viral lung immunopathology during acute respiratory syncytial virus infection in mice. PLoS One 2012, 7:e32371. 10.1371/journal.pone.0032371, 3290561, 22393401.
28. McNamara PS, Smyth RL. The pathogenesis of respiratory syncytial virus disease in childhood. Br Med Bull 2002, 61:13-28. 10.1093/bmb/61.1.13, 11997296.
29. Collins PL, Melero JA. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res 2011, 162:80-99. 10.1016/j.virusres.2011.09.020, 3221877, 21963675.
30. Graham BS, Johnson TR, Peebles RS. Immune-mediated disease pathogenesis in respiratory syncytial virus infection. Immunopharmacology 2000, 48:237-247. 10.1016/S0162-3109(00)00233-2, 10960663.
31. Moore ML, Newcomb DC, Parekh VV, Van Kaer L, Collins RD, Zhou W, Goleniewska K, Chi MH, Mitchell D, Boyce JA, et al. STAT1 negatively regulates lung basophil IL-4 expression induced by respiratory syncytial virus infection. J Immunol 2009, 183:2016-2026. 10.4049/jimmunol.0803167, 19587017.
32. Shirey KA, Pletneva LM, Puche AC, Keegan AD, Prince GA, Blanco JC, Vogel SN. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol 2010, 3:291-300. 10.1038/mi.2010.6, 2875872, 20404812.
33. Izumo T, Maekawa T, Ida M, Noguchi A, Kitagawa Y, Shibata H, Yasui H, Kiso Y. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int Immunopharmacol 2010, 10:1101-1106. 10.1016/j.intimp.2010.06.012, 20601181.